Richard John Jones

机构：Sidney Kimmel Comprehensive Cancer Center · ORCID：0000-0002-2946-1164

发表论文 492 篇 · 总被引 25204 次 · h-index 83

代表论文

• Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 (2024 · Journal of Clinical Oncology · 被引 222)
• Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial (2024 · The Lancet · 被引 53)
• Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML (2025 · Blood · 被引 51)
• Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703 (2025 · Blood Advances · 被引 15)
• Is allogeneic transplantation for sickle cell disease still relevant in the era of gene therapy? (2024 · Blood Advances · 被引 12)
• Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide (2024 · Bone Marrow Transplantation · 被引 12)